AP3 is a plant aspartic protease with cytotoxic activity toward a broad spectrum of pathogens, including potato and human pathogen microorganisms, and cancer cells, but not against human T cells, human red blood cells or plant cells. For this reason, AP3 could be a promising and potential drug candidate for future therapies. In this work, the improvement of the performance of AP3 was achieved by means of a modification with PEG. The separation of a mono-PEGylated AP3 fraction was easily performed by gel filtration chromatography. The mono-PEGylated AP3 fraction was studied in terms of antimicrobial activity, exhibiting higher antimicrobial activity against spores and , but slightly lower activity against than native protein. Such increase in antifungal activity has not been reported previously for a PEGylated plant protein. In addition, PEGylation did not affect the selective cytotoxicity of AP3, since no hemolytic activity was observed.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466107 | PMC |
http://dx.doi.org/10.1016/j.btre.2014.05.007 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!